OnCo
technologiesTechnologyStandard of care

HPV & HBV vaccination

Vaccines that prevent the viral infections behind cervical, throat, anal, and liver cancers. The most effective anti-cancer intervention ever created.

Gardasil 9 prevents ~90% of cervical cancers; Scotland and Sweden report near-zero cervical cancer in fully vaccinated cohorts. WHO targets cervical cancer elimination (90-70-90). HBV vaccination has reduced liver cancer incidence in Taiwan and elsewhere. Single-dose HPV schedules expand coverage.

Schematic · not to scale
Virus-like particle (L1 capsid) · No viral DNA inside

How it works

Virus-like particle vaccines induce neutralising antibodies preventing persistent oncogenic infection.

Strengths
  • Prevents cancer outright
  • Cheap at scale
Limitations
  • Coverage gaps, vaccine hesitancy

Products

1top

Key papers

3top

Latest papers

top
Literature trend1,509 papers in the last 12 months+17% vs prior 12How this is computed
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this technology: (TITLE:"HPV vaccination" OR ABSTRACT:"HPV vaccination" OR TITLE:"HPV vaccine" OR ABSTRACT:"HPV vaccine" OR TITLE:"cervical cancer elimination" OR ABSTRACT:"cervical cancer elimination"). Results are unfiltered search hits about HPV & HBV vaccination, not a curated reading list.

Connected

77top

cancers

5

fronts

1

technologies

3

drugs

1

institutions

28

pathways

5

terms

6

trials

2

roadmaps

1

ideas

10

people

9

bottlenecks

3

key papers

3